Dapagliflozin In Alzheimer's Disease

Clinical trial NCT03801642 · COMPLETED

Trial details

NCT number: NCT03801642
Sponsor: Jeff Burns, MD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-01-29
Primary completion: 2022-07-07
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.